- Home
- VRXA vs NAGE Comparison
VRXA vs NAGE Comparison
Compare VRXA & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRXA | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.0M | 239.0M |
| IPO Year | 2025 | 2010 |
Fundamental Metrics
Financial Performance| Metric | VRXA | NAGE |
|---|---|---|
| Price | $1.65 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 380.8K | ★ 398.0K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $33.89 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $1.27 | $2.87 |
| 52 Week High | $4.50 | $10.52 |
Technical Indicators
Market Signals| Indicator | VRXA | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 41.88 |
| Support Level | $1.27 | $2.91 |
| Resistance Level | $1.99 | $3.61 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 52.05 | 13.43 |
Price Performance
Historical ComparisonAbout VRXA Veraxa Biotech AG Ordinary Shares
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.